Emerging drugs for cancer cachexia

JOURNAL ARTICLE published November 2007 in Expert Opinion on Emerging Drugs

Authors: Josep M Argilés | Francisco J López-Soriano | Sílvia Busquets

JOURNAL ISSUE published March 2006 in Expert Opinion on Emerging Drugs

Emerging treatments forallergic rhinitis

JOURNAL ARTICLE published May 2003 in Expert Opinion on Emerging Drugs

Authors: Morgan Andersson

The unexpected side effects of new nonsteroidal anti-inflammatory drugs

JOURNAL ARTICLE published November 2005 in Expert Opinion on Emerging Drugs

Authors: Andre Uzan

New pharmacological treatment options for irritable bowel syndrome with constipation

JOURNAL ARTICLE published 2 October 2015 in Expert Opinion on Emerging Drugs

Authors: Salman Nusrat | Philip B. Miner

Related articles

JOURNAL ARTICLE published June 2013 in Expert Opinion on Emerging Drugs

Treatment strategies for acromegaly

JOURNAL ARTICLE published November 2005 in Expert Opinion on Emerging Drugs

Authors: Ferdinand Roelfsema | Nienke R Biermasz | Johannes A Romijn | Alberto M Pereira

Emerging drugs for urothelial (bladder) cancer

JOURNAL ARTICLE published 3 April 2017 in Expert Opinion on Emerging Drugs

Authors: Kerwin Cumberbatch | Tianfang He | Zachary Thorogood | Benjamin A Gartrell

Emerging mAbs for the treatment of esophagogastric cancer

JOURNAL ARTICLE published 2 January 2015 in Expert Opinion on Emerging Drugs

Authors: Geoffrey Y Ku | David H Ilson

Emerging tyrosine kinase inhibitors for esophageal cancer

JOURNAL ARTICLE published June 2013 in Expert Opinion on Emerging Drugs

Authors: Geoffrey Y Ku | David H Ilson

Therapeutic strategies in nonalcoholic fatty liver disorders

JOURNAL ARTICLE published May 2005 in Expert Opinion on Emerging Drugs

Authors: F Fred Poordad

Emerging drugs for secondary hyperparathyroidism

JOURNAL ARTICLE published 3 April 2015 in Expert Opinion on Emerging Drugs

Authors: Mario Cozzolino | James Tomlinson | Liron Walsh | Antonio Bellasi

JOURNAL ISSUE published December 2008 in Expert Opinion on Emerging Drugs

Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists

JOURNAL ARTICLE published March 2012 in Expert Opinion on Emerging Drugs

Authors: David R. Janero

Emerging drugs for biliary cancer

JOURNAL ARTICLE published March 2014 in Expert Opinion on Emerging Drugs

Authors: Takuji Okusaka | Hidenori Ojima | Chigusa Morizane | Masafumi Ikeda | Tatsuhiro Shibata

Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on

JOURNAL ARTICLE published September 2013 in Expert Opinion on Emerging Drugs

Authors: Elio Castagnola | Malgorzata Mikulska | Paola Barabino | Ines Lorenzi | Riccardo Haupt | Claudio Viscoli

Emerging drugs in metastatic breast cancer

JOURNAL ARTICLE published March 2009 in Expert Opinion on Emerging Drugs

Authors: Omer Dizdar | Kadri Altundag

Emerging corticosteroid agonists for the treatment of asthma

JOURNAL ARTICLE published 2 October 2015 in Expert Opinion on Emerging Drugs

Authors: Christian G Westergaard | Celeste Porsbjerg | Vibeke Backer

Histatin-derived peptides: potential agents to treat localised infections

JOURNAL ARTICLE published May 2002 in Expert Opinion on Emerging Drugs

Authors: David M Rothstein | Phillip Friden | Peter Spacciapoli | Frank G Oppenheim | Eva J Helmerhorst

Emerging drugs for colorectal cancer

JOURNAL ARTICLE published December 2008 in Expert Opinion on Emerging Drugs

Authors: David R Fogelman | Scott Kopetz | Cathy Eng